THERALINK TECHNOLOGIES, INC.
company.status.inactiveCIK 1362703fmd_04NY6K74AW24PTAM5Y9JSH918RManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Mar 01, 2006 to Dec 31, 2023, 63 periods
Latest annual · FY2023
Millions- Total revenues
- 1
- Gross profit
- 0
- Operating income
- (9)
- Net income
- (31)
- Free cash flow
- (6)
Latest quarter · Q1 FY2024
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (2)
- Net income
- (19)
- Free cash flow
- (2)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- +49.6%
- Revenue, 5 yearsFY2019 to FY2023
- n/m
- Net income, 5 yearsFY2019 to FY2023
- n/m
THERALINK TECHNOLOGIES, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $606,796 | $567,905 | +6.8% | 10-K 2024-01-05 · proof |
| Gross profit | $480,559 | $343,019 | +40.1% | 10-K 2024-01-05 · proof |
| Operating income | -$9 million | -$11.6 million | 10-K 2024-01-05 · proof | |
| Net income | -$30.9 million | -$12.7 million | 10-K 2024-01-05 · proof | |
| Cash from operating activities | -$5.8 million | -$5.4 million | 10-K 2024-01-05 · proof | |
| Free cash flow | -$5.9 million | -$5.5 million | 10-K 2024-01-05 · proof | |
| Total assets | $2.8 million | $2.6 million | +9.7% | 10-K 2024-01-05 · proof |
| Total liabilities | $41 million | $6.4 million | +540.1% | 10-K 2024-01-05 · proof |
| Cash and cash equivalents | $997,484 | $393,460 | +153.5% | 10-K 2024-01-05 · proof |
- What was THERALINK TECHNOLOGIES, INC.'s revenue in fiscal 2023?
- THERALINK TECHNOLOGIES, INC. reported revenue of $606,796 for fiscal 2023 (the year ended Sep 30, 2023), against $567,905 the year before (+6.8%). Source: the 10-K filed with the SEC on Jan 5, 2024. SEC
- What was THERALINK TECHNOLOGIES, INC.'s gross profit in fiscal 2023?
- THERALINK TECHNOLOGIES, INC. reported gross profit of $480,559 for fiscal 2023 (the year ended Sep 30, 2023), against $343,019 the year before (+40.1%). Source: the 10-K filed with the SEC on Jan 5, 2024. SEC
- What was THERALINK TECHNOLOGIES, INC.'s operating income in fiscal 2023?
- THERALINK TECHNOLOGIES, INC. reported operating income of -$9 million for fiscal 2023 (the year ended Sep 30, 2023), against -$11.6 million the year before. Source: the 10-K filed with the SEC on Jan 5, 2024. SEC
- What was THERALINK TECHNOLOGIES, INC.'s net income in fiscal 2023?
- THERALINK TECHNOLOGIES, INC. reported net income of -$30.9 million for fiscal 2023 (the year ended Sep 30, 2023), against -$12.7 million the year before. Source: the 10-K filed with the SEC on Jan 5, 2024. SEC
- What was THERALINK TECHNOLOGIES, INC.'s cash from operating activities in fiscal 2023?
- THERALINK TECHNOLOGIES, INC. reported cash from operating activities of -$5.8 million for fiscal 2023 (the year ended Sep 30, 2023), against -$5.4 million the year before. Source: the 10-K filed with the SEC on Jan 5, 2024. SEC
- What was THERALINK TECHNOLOGIES, INC.'s free cash flow in fiscal 2023?
- THERALINK TECHNOLOGIES, INC. reported free cash flow of -$5.9 million for fiscal 2023 (the year ended Sep 30, 2023), against -$5.5 million the year before. Source: the 10-K filed with the SEC on Jan 5, 2024. SEC
- What are THERALINK TECHNOLOGIES, INC.'s total assets?
- As of Sep 30, 2023, THERALINK TECHNOLOGIES, INC. reported total assets of $2.8 million, against $2.6 million a year earlier (+9.7%). Source: the 10-K filed with the SEC on Jan 5, 2024. SEC
- What are THERALINK TECHNOLOGIES, INC.'s total liabilities?
- As of Sep 30, 2023, THERALINK TECHNOLOGIES, INC. reported total liabilities of $41 million, against $6.4 million a year earlier (+540.1%). Source: the 10-K filed with the SEC on Jan 5, 2024. SEC
- What are THERALINK TECHNOLOGIES, INC.'s cash and cash equivalents?
- As of Sep 30, 2023, THERALINK TECHNOLOGIES, INC. reported cash and cash equivalents of $997,484, against $393,460 a year earlier (+153.5%). Source: the 10-K filed with the SEC on Jan 5, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1362703&period_type=annual&limit=5"Information only, not investment advice.